FDA Approves New Drug For Hepatitis A And Measles Exposure
GamaSTAN ®, is the only immune globulin product available in the United States to protect against hepatitis A virus (HAV) and measles after exposure, the company said. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 12, 2018 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news

FDA Clears New Immune Globulin for Measles, Hep A, Exposure FDA Clears New Immune Globulin for Measles, Hep A, Exposure
GamaSTAN (immune globulin [human]) is for prophylaxis following exposure to hepatitis A and prevention of measles in susceptible individuals exposed fewer than 6 days previously.FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 10, 2018 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

FDA Approves New Formulation of HepA Immune Globulin
(MedPage Today) -- Product also offers post-exposure prophylaxis against measles (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 6, 2018 Category: American Health Source Type: news

Privigen (Immune Globulin Intravenous) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 31, 2018 Category: Drugs & Pharmacology Source Type: news

Rhophylac (Immune Globulin Intravenous (Human) solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 31, 2018 Category: Drugs & Pharmacology Source Type: news

Hizentra (Immune Globulin Subcutaneous (Human) Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 26, 2018 Category: Drugs & Pharmacology Source Type: news

Carimune (Immune Globulin Intravenous (Human) Nanofiltered Lyophilized Preparation) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 12, 2018 Category: Drugs & Pharmacology Source Type: news

HepaGam B (Hepatitis B Immune Globulin (Human)) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 6, 2018 Category: Drugs & Pharmacology Source Type: news

BabyBIG (Botulism Immune Globulin Intravenous (Human) (BIG-IV) for Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 7, 2018 Category: Drugs & Pharmacology Source Type: news

BabyBIG (Botulism Immune Globulin Intravenous (Human) (BIG-IV) for Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 2, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Hizentra(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
First and only subcutaneous immunoglobulin (SCIg) approved for the treatment of CIDP based on the largest controlled clinical study in CIDP KING OF PRUSSIA, Pa., March 16, 2018 -- (Healthcare Sales & Marketing Network) -- Global biotherapeutics leader ... Biopharmaceuticals, FDA CSL Behring, Hizentra, Immune Globulin, CIDP (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 16, 2018 Category: Pharmaceuticals Source Type: news

Gammaked (Immune Globulin (Human), 10% Caprylate/Chromatography Purified Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 16, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
KING OF PRUSSIA, Pa. – March 16, 2018 – Global biotherapeutics leader CSL Behring today announced that the U.S. Food and Drug Administration (FDA) approved Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid) as the first and only... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 16, 2018 Category: Drugs & Pharmacology Source Type: news

A diagnosis you can ’t afford to miss
4 out of 5 stars Antibody-Mediated Encephalitis. Dalmau J, Graus F. N Engl J Med 2018 Mar 1;378:840-851. Reference TPR has posted before about anti-NMDA receptor encephalitis, a must-know, can’t-miss, humbling diagnosis that is distressingly easy to overlook. Although it is not a toxicologic condition, all toxicologists and emergency physicians should be thoroughly familiar with its presentation and clinical course. Let me explain why. NMDAR encephalitis often begins with behavioral changes, mood swings, and memory deficits in relatively young patients. According to this somewhat technical but excellent review, the ...
Source: The Poison Review - March 2, 2018 Category: Toxicology Authors: Leon Gussow Tags: Medical anbitody-mediated encephalitis anti-NMDA receptor encephalitis brain on fire diagnosis Source Type: news

Potential Confounding of Diagnosis of Rabies in Patients with Recent Receipt of Intravenous Immune Globulin
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - February 8, 2018 Category: American Health Source Type: news